TY - JOUR
T1 - Complete Genome Sequence of the Apicomplexan, Cryptosporidium parvum
AU - Abrahamsen, Mitchell S.
AU - Templeton, Thomas J.
AU - Enomoto, Shinichiro
AU - Abrahante, Juan E.
AU - Zhu, Guan
AU - Lancto, Cheryl A.
AU - Deng, Mingqi
AU - Liu, Chang
AU - Widmer, Giovanni
AU - Tzipori, Saul
AU - Buck, Gregory A.
AU - Xu, Ping
AU - Bankier, Alan T.
AU - Dear, Paul H.
AU - Konfortov, Bernard A.
AU - Spriggs, Helen F.
AU - Iyer, Lakshminarayan
AU - Anantharaman, Vivek
AU - Aravind, L.
AU - Kapur, Vivek
PY - 2004/4/16
Y1 - 2004/4/16
N2 - The apicomplexan Cryptosporidium parvum is an intestinal parasite that affects healthy humans and animals, and causes an unrelenting infection in immunocompromised individuals such as AIDS patients. We report the complete genome sequence of C. parvum, type II isolate. Genome analysis identifies extremely streamlined metabolic pathways and a reliance on the host for nutrients. In contrast to Plasmodium and Toxoplasma, the parasite lacks an apicoplast and its genome, and possesses a degenerate mitochondrion that has lost its genome. Several novel classes of cell-surface and secreted proteins with a potential role in host interactions and pathogenesis were also detected. Elucidation of the core metabolism, including enzymes with high similarities to bacterial and plant counterparts, opens new avenues for drug development.
AB - The apicomplexan Cryptosporidium parvum is an intestinal parasite that affects healthy humans and animals, and causes an unrelenting infection in immunocompromised individuals such as AIDS patients. We report the complete genome sequence of C. parvum, type II isolate. Genome analysis identifies extremely streamlined metabolic pathways and a reliance on the host for nutrients. In contrast to Plasmodium and Toxoplasma, the parasite lacks an apicoplast and its genome, and possesses a degenerate mitochondrion that has lost its genome. Several novel classes of cell-surface and secreted proteins with a potential role in host interactions and pathogenesis were also detected. Elucidation of the core metabolism, including enzymes with high similarities to bacterial and plant counterparts, opens new avenues for drug development.
UR - http://www.scopus.com/inward/record.url?scp=11144353587&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=11144353587&partnerID=8YFLogxK
U2 - 10.1126/science.1094786
DO - 10.1126/science.1094786
M3 - Article
C2 - 15044751
AN - SCOPUS:11144353587
SN - 0036-8075
VL - 304
SP - 441
EP - 445
JO - Science
JF - Science
IS - 5669
ER -